CIK 0000879407
- Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460408024
- Phone
- +1 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Operating Officer acquired 150,000 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 23,347 shares at $6.13 ($143,117)
- 4 Shares withheld for taxes Chief Executive Officer gave up 58,712 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Operating Officer acquired 150,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 360,000 shares (grant or award)
- 4 Grant or award CFO acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 35,000 shares (grant or award)
- 4 Open-market buy Director bought 2,300 shares at an average $6.44 ($14,808)
- 4 Open-market sale Chief Scientific Officer sold 15,000 shares at $8.01 ($120,104)
Page 16 of 25 · 497 filings